Detailed price information for IM Cannabis Corp (IMCC-Q) from The Globe and Mail including charting and trades.
VANCOUVER, BC and GLIL YAM, Israel, Sept. 29, 2026/ PRNewswire/-- IM Cannabis Corp., today announced that, further to its press releases dated June 18, 2026 and August 17, 2026, it has completed the previously announced transaction contemplated by the definitive share purchase agreement dated August 16, 2026 among the Company, Slil.com Holding Ltd. and I.M.C....
Detailed price information for IM Cannabis Corp (IMCC-Q) from The Globe and Mail including charting and trades.
U.S. stocks fell Wednesday, led by a 1.1% Nasdaq drop. Cintas beat estimates and raised guidance; oil gained while gold, silver and copper declined.
IM Cannabis stock reverses an earlier surge after a $1.31 million share offering followed its non-binding defense-tech deal.
Gainers IM Cannabis (NASDAQ:IMCC) stock rose 56.3% to $6.47 during Wednesday's pre-market session. The company's market cap stands at $2.5 million. Vistagen Therapeutics (NASDAQ:VTGN) shares increased by
IM Cannabis Corp. ("IMCC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced the closing of a US$225,000 convertible note financing in a private placement with an institutional investor (the "Lender").
Detailed price information for IM Cannabis Corp (IMCC-Q) from The Globe and Mail including charting and trades.
IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, announces that, further to its press release dated August 18, 2026, the Company's common shares, no par value per share ("Common Shares"), commenced trading today on the Nasdaq Capital Market LLC ("Nasdaq") on a 30:1 post-consolidated basis (the "Consolidation").
This is the newest page. Registered accounts read further back.